Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249652 · ClinicalTrials.gov registry record · Phase 1
Transplant and Addiction Project (TAP) - 1
A Phase 1 study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00249652 is a Phase 1 study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 41 participants.
The verdict
NCT00249652, a Phase 1 study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to test a novel distance-based (telephone) intervention to help transplant candidates with current or recent substance abuse to stay "clean and sober" both prior and following transplant surgery.
Interventions
- OTHER TAU
- BEHAVIORAL TAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00249652
The ClinicalTrials.gov registry entry for NCT00249652 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAU is the first listed.
NCT00249652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00249652 about?
NCT00249652 is a clinical study titled "Transplant and Addiction Project (TAP) - 1". The purpose of this study is to test a novel distance-based (telephone) intervention to help transplant candidates with current or recent substance abuse to stay "clean and sober" both prior and following transplant surgery.
What is the current status of trial NCT00249652?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2003-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00249652?
The interventions under investigation include: TAU (OTHER), TAP (BEHAVIORAL).
Who is sponsoring clinical trial NCT00249652?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.